Vivus promotes Peter Tam to president

Vivus has promoted its COO, Peter Tam, to president. Tam has held various leadership positions at Vivus over the last 16 years, including director of clinical and corporate development, senior vice president of product and corporate development and chief operating officer. Vivus release

Rosetta Genomics announced the appointment of Kenneth A. Berlin to the position of president and CEO. Release

Mara Aspinall, a former senior executive at Genzyme, is taking the helm of On-Q-ity, a new cancer diagnostics business. Story

NeoPharm announced the appointment of Dr. Aquilur Rahman to the position of president and CEO. NeoPharm release

Codexis has named Robert Lawson as senior vice president and chief financial officer. Read Codexis release

Medicure announced the appointment of Eric Johnstone as chief financial officer. Check out Medicure release

Watson Pharmaceuticals named Todd Joyce as senior vice president and chief financial officer, succeeding Mark Durand, who left for personal reasons. Story

Alnara Pharmaceuticals announced the appointment of Lee R. Brettman, M.D., FACP, to the newly created position of chief medical officer. Read the Alnara release

Chelsea Therapeutics named Dr. William Schwieterman to the newly created position of chief medical officer. Report

Ferring Pharmaceuticals has named Harry F. Kovelman, MD as associate medical director for Orthopaedics. Release

Emergent Technologies announced that David Sougstad has been hired as the new executive director of the Abilene Life Sciences Accelerator. Release

SV Life Sciences announced the appointment of two new venture partners, Patrick T. Ryan and James C. Wachtman, both of whom will be based in the firm`s Boston office. Release

David Kennedy has joined Girindus as director of operations. Release

Laureate Pharma added three new members to its business development team. Andrew Arrage joins Laureate as Director, Business Development - East; Patricia Caplan joins Laureate as Director, Business Development - East; and Bruce Frazier joins Laureate as Manager, Business Development - West. Release

INC Research named Wayne Whittingham as vice president, regulatory affairs and strategic drug development. Release

The Board

Affymax named Hollings C. Renton - the former chairman of Onyx--to the position of chairman of the board, replacing Nick Galakatos, who served as lead board member since the company`s initial public offering in 2006 and who will be resigning his position as a member of the board of directors at the end of 2009. Release

Amicus Therapeutics has named Margaret G. McGlynn, R.Ph., to its board of directors. McGlynn most recently served as president of vaccines and infectious diseases for Merck. Release

Fresenius Kabi Pharmaceuticals Holding, which acquired APP Pharmaceuticals on September 10, 2008, announced the election of Bernhard Hampl, Ph.D. to its board of directors. Release

David Stout, once a contender for the helm at GlaxoSmithKline, has been named a director at Shire. Story

Quintiles Executive Vice President and Chief Information Officer William "Bill" Deam has been named to the "CIO Hall of Fame." Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.